本页面由Tiger Trade Technology Pte. Ltd.提供服务

CNS Pharmaceuticals, Inc.

2.66
-0.0900-3.27%
盘后2.660.00000.00%16:20 EDT
成交量:2.29万
成交额:6.18万
市值:215.83万
市盈率:-0.07
高:2.85
开:2.85
低:2.58
收:2.75
52周最高:34.80
52周最低:2.06
股本:81.14万
流通股本:71.50万
量比:0.57
换手率:3.20%
股息:- -
股息率:- -
每股收益(TTM):-35.7503
每股收益(LYR):-466.4490
净资产收益率:-296.30%
总资产收益率:-115.35%
市净率:0.48
市盈率(LYR):-0.01

数据加载中...

2020/03/26

重要事件披露

Current report, items 1.01 and 9.01
2020/03/12

重要事件披露

Current report, items 2.02 and 9.01
2020/03/12

年度报告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/03/10

重要事件披露

Current report, items 7.01 and 9.01
2020/03/02

重要事件披露

Current report, items 7.01 and 9.01
2020/01/16

重要事件披露

Current report, items 1.01, 7.01, and 9.01
2020/01/16

重要事件披露

Current report, items 7.01 and 9.01
2020/01/13

重要事件披露

Current report, items 7.01 and 9.01
2019/12/20

季度报告

Quarterly report [Sections 13 or 15(d)]
2019/11/22

重要事件披露

Current report, items 8.01 and 9.01
2019/11/14

重要事件披露

Current report, items 5.02, 8.01, and 9.01
2019/11/05

SEC问询函

[Cover]Correspondence
2019/11/05

SEC问询函

[Cover]Correspondence
2019/10/15

[补充]招股说明书

Filing under Securities Act Rules 163/433 of free writing prospectuses
2019/10/10

[补充]招股说明书

Filing under Securities Act Rules 163/433 of free writing prospectuses
2019/10/07

[修订]招股说明书

[Amend] General form for registration of securities under the Securities Act of 1933
2019/08/22

[修订]招股说明书

[Amend] General form for registration of securities under the Securities Act of 1933
2019/07/16

[修订]招股说明书

[Amend] General form for registration of securities under the Securities Act of 1933
2019/07/16

SEC问询函

[Cover]Correspondence
2019/07/16

[补充]招股说明书

Filing under Securities Act Rules 163/433 of free writing prospectuses